Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma
International Journal of Molecular Sciences · 16.05.2023 · 24 (10) · 8861
DOI: 10.3390/ijms24108861 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.05.2023. Verfasst von Maria Chiara Gelmi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Microphthalmos, Uveal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bontius Foundation, Stichting Oogfonds Nederland, The Sam Fund.
Abstract (Originalsprache)
Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. In cutaneous melanoma, MITF loss has been linked to an increased expression of stem cell markers, a shift in epithelial-to-mesenchymal transition (EMT)-related factors, and increased inflammation. We explored the role of MITF in Uveal Melanoma (UM) using a cohort of 64 patients enucleated at the Leiden University Medical Center. We analysed the relation between MITF expression and clinical, histopathological and genetic features of UM, as well as survival. We performed differential gene expression and gene set enrichment analysis using mRNA microarray data, comparing MITF-low with MITF-high UM. MITF expression was lower in heavily pigmented UM than in lightly pigmented UM (p = 0.003), which we confirmed by immunohistochemistry. Furthermore, MITF was significantly lower in UM with monosomy 3/BAP1 loss than in those with disomy 3/no BAP1 loss (p < 0.001) and with 8q gain/amplification 8q (p = 0.02). Spearman correlation analysis showed that a low MITF expression was associated with an increase in inflammatory markers, hallmark pathways involved in inflammation, and epithelial-mesenchymal transition. Similar to the situation in cutaneous melanoma, we propose that MITF loss in UM is related to de-differentiation to a less favourable EMT profile and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
- Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
- Department of Pathology, Section Ophthalmic Pathology, Erasmus MC University Medical Center, 3000 CA Rotterdam, The Netherlands.
- Department of Clinical Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
ORCID-Profile: Maria Chiara Gelmi, Robert M Verdijk, Laurien E Houtzagers, Martine J Jager
Förderung
- Bontius Foundation
- Stichting Oogfonds Nederland
- The Sam Fund
- LUF
- P.A. Jager - van Gelder Fund
- Blinden-Penning foundation
- ASROO (Associazione Scientifica Retinoblastoma ed Oncologia Oculare)
- the Bontius Foundation
Zitieren
APA
Gelmi, M. C., Verdijk, R. M., Houtzagers, L. E., van der Velden, P. A., Kroes, W. G. M., Luyten, G. P. M., Vu, T. H. K., & Jager, M. J. (2023). Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma. International Journal of Molecular Sciences, 24(10), 8861. https://doi.org/10.3390/ijms24108861
Vancouver
Gelmi MC, Verdijk RM, Houtzagers LE, van der Velden PA, Kroes WGM, Luyten GPM, et al. Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma. International Journal of Molecular Sciences. 2023;24(10):8861. doi:10.3390/ijms24108861
BibTeX
@article{Gelmi2023,
author = {Gelmi, Maria Chiara and Verdijk, Robert M and Houtzagers, Laurien E and van der Velden, Pieter A and Kroes, Wilma G M and Luyten, Gregorius P M and Vu, T H Khanh and Jager, Martine J},
title = {Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8861},
doi = {10.3390/ijms24108861}
}
EUVIMED